Pharmaceuticals
6 companies analysed from SEC EDGAR filings. Compare valuations, profitability, and risk across the sector.
Macro regime signal · XLV
Current: Inflationary BoomNeutral★★★★★
Inflation-linked pricing in some segments. Mixed overall.
Signal across all regimes
Goldilocks
Neutral★★★★★
Inflationary Boom ←
Neutral★★★★★
Stagflation
Overweight★★★★★
Deflationary Bust
Strong buy★★★★★
Liquidity Boom
Underweight★★★★★
Rate Hike Cycle
Neutral★★★★★
Rate Cut Anticipation
Overweight★★★★★
Volatility Shock
Strong buy★★★★★
Companies
6
Total mkt cap
—
Sector P/E (ETF)
—
Avg gross margin
35.5%
Strong / Positive
0
Caution / At Risk
0
Metrics comparison
| Company | Mkt Cap↓ | P/E (vs sector) | Gross Margin | Net Margin | D/E Ratio | Risks |
|---|---|---|---|---|---|---|
| MRNAModerna, Inc. | — | — | — | -14.6% | 0.07 | 2 |
| AMGNAmgen Inc. | — | — | 18.6% | 30.3% | 6.31 | 1 |
| BIIBBIOGEN INC. | — | — | 117.7% | 13.1% | 0.42 | 1 |
| OTLKOUTLOOK THERAPEUTICS, INC. | — | — | 0.7% | -766.3% | — | 5 |
| NVAXNOVAVAX, INC. | — | — | — | 39.2% | — | 3 |
| HALOHALOZYME THERAPEUTICS, INC. | — | — | 5.1% | 260.4% | 43.89 | 3 |